Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.

Pharmacogenetics and genomics - 1 Aug 2009

Ferris Steven, Nordberg Agneta, Soininen Hilkka, Darreh-Shori Taher, Lane Roger

Abstract excerpt

OBJECTIVE: Evaluate the effect of sex and butyrylcholinesterase (BuChE) genotype on the incidence of Alzheimer's disease (AD), cognitive and functional decline, brain volume changes, and response to rivastigmine treatment in individuals with mild cognitive impairment (MCI). METHODS: This retrospective exploratory analysis from a 3-4 year, randomized, placebo-controlled study of rivastigmine in MCI patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Butyrylcholinesterase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholinesterase Inhibitors

Share to Cognition

Share to Cognition Disorders

Share to Neuroprotective Agents

Share to Pharmacogenetics

Share to Placebos

Source

Open in PubMed Open full text

Identifiers

PMID: 19617863
DOI: 10.1097/FPC.0b013e32832f8c17
PMCID: PMC4114757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.PMID 19617863Read ↗

Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.Semantic proximity Read ↗

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.Semantic proximity Read ↗

Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype.Semantic proximity Read ↗

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.Semantic proximity Read ↗

Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.Semantic proximity Read ↗

Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memorySemantic proximity Read ↗

Sex Differences in the Relationship of Biomarker Change to Memory Decline in Early Alzheimer’s Disease: an Observational Cohort StudySemantic proximity Read ↗

Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory.Semantic proximity Read ↗

Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype.Semantic proximity Read ↗

Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.Semantic proximity Read ↗

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.Semantic proximity Read ↗

The sex-specific effect of the apolipoprotein E allele and methylenetetrahydrofolate reductase gene polymorphism on the biochemical, anatomical, and cognitive profiles of patients clinically diagnosed with probable Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.